Advertisement CDC Expands Vaccine Distribution Partnership With McKesson - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

CDC Expands Vaccine Distribution Partnership With McKesson

To include preparations for H1N1 flu vaccine distribution

McKesson has reported that its current partnership with the Centers for Disease Control and Prevention (CDC) has been expanded to include preparations for H1N1 flu vaccine distribution.

CDC currently has a contract with McKesson for distribution of its public-sector purchased adult and pediatric vaccines, including those distributed through the ‘Vaccines for Children’ Program.

Under the authority of Unusual and Compelling Urgency, CDC is expanding its existing contract with McKesson to include centralized distribution of the H1N1 flu vaccine, currently under development.

Reportedly, the H1N1 vaccine distribution effort will include the centralized distribution of the H1N1 flu vaccine to as many as 90,000 sites across the country.

The US Department of Health and Human Services (HHS) and CDC are working with state and local public health officials and vaccine manufacturers to develop the timeline and plan for distribution and administration of the H1N1 flu vaccine to the public.

Moreover, McKesson’s role will be to distribute the vaccine to sites designated by state health departments across the country.

Paul Julian, executive vice president and group president of McKesson, said: “McKesson is pleased to expand our partnership with the CDC, and we are committed to our role in this unprecedented H1N1 preparedness effort.We look forward to continuing to support the CDC in meeting its public health objectives.